kaken pharmaceutical co ltd
(4521:Tokyo Stock Exchange)
|Age||Total Calculated Compensation||This person is connected to 15 board members in 1 different organizations across 5 different industries.|
See Board Relationships
Mr. Takao Endo served as the Chief Executive Officer of Japan Region at Asurion, LLC. Mr. Endo served as the Chairman and Chief Executive Officer at Renesas Electronics Corporation from June 24, 2015 to December 25, 2015. He is responsible for growing Asurion’s business, building client relationships, developing the Japan organization and leveraging the global capabilities of Asurion where appropriate. He served as an Executive Adviser to Chief Executive Officer at Renesas ...
28 - 8, Honkomagome 2-chomePhone: 81 3 5977 5001
Tokyo, -- 113-8650
Fax: 81 3 5977 5131
Board Members Memberships*There is no Board Members Memberships data available.
Tokyo University of Science
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.